GNI Group Ltd.
Status: Publicly traded
Direct answer
GNI Group Ltd. is publicly traded on JPX under the ticker 2160.T.
GNI Group Ltd. is a global biopharmaceutical enterprise dedicated to the research, development, manufacturing, and commercialization of both modern pharmaceuticals and traditional Chinese medicines. The company's lead product, Etuary, is currently available for the treatment of idiopathic pulmonary fibrosis. Beyond this, Etuary is undergoing further clinical evaluation: it is in Phase III trials for connective...
Can you invest in GNI Group Ltd.?
Yes. GNI Group Ltd. trades publicly on JPX as 2160.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for GNI Group Ltd.
Detailed equity research is provided by MarketSnap.